SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-106551
Filing Date
2020-09-18
Accepted
2020-09-18 16:35:07
Documents
3
Effectiveness Date
2020-09-18

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2030766d2_defa14a.htm DEFA14A 27965
2 GRAPHIC image_001.jpg GRAPHIC 10093
3 GRAPHIC image_002.jpg GRAPHIC 7107
  Complete submission text file 0001104659-20-106551.txt   53125
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-36410 | Film No.: 201184355
SIC: 2834 Pharmaceutical Preparations